Results of the present study uncovered a novel molecular mechanism that baicalein acts as a cisplatin sensitizer, via inhibition of CirSLC7A6/miR-2682-5p/SLC7A6 in ovarian cancer. This evidence concerns the gene SLC7A6 and ovarian cancer.